Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05957536
Title A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors D3 Bio (Wuxi) Co., Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
D3 Bio Investigative Site RECRUITING Stanford California 94305 United States Details
D3 Bio Investigative Site RECRUITING Boston Massachusetts 02215 United States Details
D3 Bio Investigative Site RECRUITING New York New York 10065 United States Details
D3 Bio Investigative Site RECRUITING San Antonio Texas 78229 United States Details
D3 Bio Investigative Site RECRUITING Sydney New South Wales 2109 Australia Details
D3 Bio Investigative Site RECRUITING Malvern Victoria 3144 Australia Details
D3 Bio Investigative Site RECRUITING Harbin Heilongjiang 150088 China Details
D3 Bio Investigative Site RECRUITING Shanghai Shanghai 200025 China Details
D3 Bio Investigative Site RECRUITING Hangzhou Zhejiang 310022 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field